Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
Minimal Residual Disease
100%
Curative Intent
100%
Circulating Tumor DNA (ctDNA)
100%
Patient Demographics
16%
Disease Relapse
16%
Survival Outcomes
16%
Clinical Validation
16%
Clinical Follow-up
16%
Clinical Performance
16%
Assay Performance
16%
Curative Intent Treatment
16%
Multigroup
16%
Plasma Cell-free DNA
16%
Predicting Diseases
16%
Medicine and Dentistry
Lung Cancer
100%
Minimal Residual Disease
100%
Circulating Tumor DNA
100%
Biological Marker
16%
Cancer Therapy
16%
Prospective Study
16%
Sensitivity and Specificity
16%
Patient Population
16%
Cell-Free DNA
16%
Diseases
16%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Minimal Residual Disease
100%
Circulating Tumor DNA
100%
Biological Marker
16%
Prospective Study
16%
Diseases
16%
Biochemistry, Genetics and Molecular Biology
Circulating Tumor DNA
100%
Prospective Study
20%
Immunoglobulin Producing Cell
20%
Immunology and Microbiology
Immunoglobulin Producing Cell
100%